FDA Approved Animal Drug Products
Author :
Publisher :
Page : 144 pages
File Size : 32,36 MB
Release : 1998
Category : Veterinary drugs
ISBN :
Author :
Publisher :
Page : 144 pages
File Size : 32,36 MB
Release : 1998
Category : Veterinary drugs
ISBN :
Author : National Research Council
Publisher : National Academies Press
Page : 276 pages
File Size : 12,28 MB
Release : 1999-01-12
Category : Medical
ISBN : 0309175771
The use of drugs in food animal production has resulted in benefits throughout the food industry; however, their use has also raised public health safety concerns. The Use of Drugs in Food Animals provides an overview of why and how drugs are used in the major food-producing animal industriesâ€"poultry, dairy, beef, swine, and aquaculture. The volume discusses the prevalence of human pathogens in foods of animal origin. It also addresses the transfer of resistance in animal microbes to human pathogens and the resulting risk of human disease. The committee offers analysis and insight into these areas: Monitoring of drug residues. The book provides a brief overview of how the FDA and USDA monitor drug residues in foods of animal origin and describes quality assurance programs initiated by the poultry, dairy, beef, and swine industries. Antibiotic resistance. The committee reports what is known about this controversial problem and its potential effect on human health. The volume also looks at how drug use may be minimized with new approaches in genetics, nutrition, and animal management.
Author : Stephen M. Kanovsky
Publisher :
Page : 672 pages
File Size : 10,59 MB
Release : 2020-09
Category : Drugs
ISBN : 9781935065876
FDLI's popular reference book, A Practical Guide to FDA's Food and Drug Law and Regulation, Seventh Edition, provides an introduction to the laws and regulations governing development, marketing, and sale of FDA-regulated products, including topics on food, drugs, medical devices, biologics, dietary supplements, cosmetics, new animal drugs, cannabis, and tobacco and nicotine products. Structured to serve as a reference and as a teaching tool, the book offers practical legal and regulatory fundamentals, and each chapter builds sequentially from the last to provide an accessible overview of the key topics relevant to practitioners of food and drug law and regulation. This book is a standard legal text in law schools and graduate regulatory programs and has been cited as a reference in judicial opinions (including the U.S. Supreme Court). This Seventh Edition includes new sections on controlled substances, compounded drugs, and cannabis and cannabis-derived compounds. It also incorporates the latest amendments to the Federal Food, Drug, and Cosmetic Act, as well as FDA regulations and guidances.
Author : Eunjoo Pacifici
Publisher : Academic Press
Page : 292 pages
File Size : 41,82 MB
Release : 2018-06-13
Category : Medical
ISBN : 0128111569
Today's challenge, especially for many newcomers to the regulated industry, is not necessarily to gather regulatory information, but to know how to interpret and apply it. The ability to discern what is important from what is not, and to interpret regulatory documents correctly, provides a valuable competitive advantage to any newcomer or established professional in this field. An Overview of FDA Regulated Products: From Drugs and Medical Devices to Food and Tobacco provides a valuable summary of the key information to unveil the meaning of critical, and often complex, regulatory concepts. Concise and easy to read with practical explanations, key points, summaries and case studies, this book highlights the regulatory processes involved in bringing an FDA regulated product from research and development to approval and market. Although the primary focus will be on the US system, this book also features global perspectives where appropriate. A valuable resource for students, professors and professionals, An Overview of FDA Regulated Products illustrates the most important elements and concepts so that the reader can focus on the critical issues and make the necessary connections to be successful. - Provides an overview of key regulatory requirements using a practical approach that features detailed discussions of hypothetical and real-world case studies in order to highlight the concepts and applications of regulations - Covers all FDA regulated products, including drugs, biologics, medical devices, cosmetics, foods, dietary supplements, cosmetics, veterinary products, tobacco and more in one single reference - Illustrates complex topics in a clear, succinct and engaging manner by breaking down technical terms and offering straightforward and easy to understand explanations
Author : United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts, Civil Liberties, and the Administration of Justice
Publisher :
Page : 196 pages
File Size : 12,26 MB
Release : 1989
Category : Drugs
ISBN :
Author : National Research Council
Publisher : National Academies Press
Page : 200 pages
File Size : 20,13 MB
Release : 2002-11-29
Category : Technology & Engineering
ISBN : 030916933X
Genetic-based animal biotechnology has produced new food and pharmaceutical products and promises many more advances to benefit humankind. These exciting prospects are accompanied by considerable unease, however, about matters such as safety and ethics. This book identifies science-based and policy-related concerns about animal biotechnologyâ€"key issues that must be resolved before the new breakthroughs can reach their potential. The book includes a short history of the field and provides understandable definitions of terms like cloning. Looking at technologies on the near horizon, the authors discuss what we know and what we fear about their effectsâ€"the inadvertent release of dangerous microorganisms, the safety of products derived from biotechnology, the impact of genetically engineered animals on their environment. In addition to these concerns, the book explores animal welfare concerns, and our societal and institutional capacity to manage and regulate the technology and its products. This accessible volume will be important to everyone interested in the implications of the use of animal biotechnology.
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Publisher :
Page : 180 pages
File Size : 19,75 MB
Release : 1987
Category : Drugs
ISBN :
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 28,83 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author : World Health Organization
Publisher : World Health Organization
Page : 0 pages
File Size : 48,31 MB
Release : 2017-11-10
Category : Business & Economics
ISBN : 9789241550130
WHO has launched new guidelines on use of medically important antimicrobials in food-producing animals, recommending that farmers and the food industry stop using antibiotics routinely to promote growth and prevent disease in healthy animals. These guidelines aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their use in animals.
Author : Mark G. Papich
Publisher : Elsevier Health Sciences
Page : 1060 pages
File Size : 50,49 MB
Release : 2020-10-06
Category : Medical
ISBN : 0323709583
**Selected for Doody's Core Titles® 2024 in Veterinary Medicine** Papich Handbook of Veterinary Drugs, 5th Edition includes concise entries for more than 550 drugs, with appendices summarizing clinically relevant information at a glance. Nineteen new drug monographs are added to this edition, and over 100 drug monographs have been updated and revised. An Expert Consult website contains more than 150 instructional handouts that may be customized and printed out for your clients. Written by clinical pharmacology expert Mark Papich, this handy reference makes it easy to find the drug data and dosage recommendations you need to treat small and large animals, right when you need it! - Over 550 concise drug monographs are organized alphabetically and cross-referenced by classification, trade, and generic name, providing quick and easy access to key information for each drug including:• Generic and trade names, pronunciation, and functional classification • Pharmacology and mechanism of action • Indications and clinical uses • Precautionary information — adverse reactions and side effects, contraindications and precautions, and drug interactions — all featured in colored boxes for at-a-glance retrieval • Instructions for use • Patient monitoring and laboratory tests • Formulations available • Stability and storage • Dosage information for both small and large animals • Regulatory information - Clinically relevant appendices help you determine appropriate therapeutic regimens and look up safety and legal considerations. - NEW! 19 new drug monographs familiarize you with the latest drugs available for veterinary practice. - UPDATED drug monographs include new information such as changes in doses, interactions, indications, adverse reactions, and contraindications. - NEW! Expert Consult companion website replaces the former website and includes more than 150 customizable client information handouts for commonly prescribed drugs, including information on the prescribed drug and dosage, do's and don'ts, and possible side effects. - NEW! Removal of entries for drugs that have been taken off the market.